Association of human papillomavirus 16 and 18 with ovarian cancer risk: Insights from a meta‑analysis
- Authors:
- Tan Minh Le
- Hong Duc Thi Nguyen
- Junghwan Cho
- Nora Jee‑Young Park
- Hyung Soo Han
- Gun Oh Chong
- Incheol Seo
-
Affiliations: Department of Biomedical Science, Graduate School, Kyungpook National University, Daegu 41944, Republic of Korea, Clinical Omics Institute, Kyungpook National University, Daegu 41405, Republic of Korea, Department of Immunology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea - Published online on: September 19, 2024 https://doi.org/10.3892/ol.2024.14689
- Article Number: 556
-
Copyright: © Le et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
Ghose A, Bolina A, Mahajan I, Raza SA, Clarke M, Pal A, Sanchez E, Rallis KS and Boussios S: Hereditary ovarian cancer: Towards a cost-effective prevention strategy. Int J Environ Res Public Health. 19:120572022. View Article : Google Scholar : PubMed/NCBI | |
Lõhmussaar K, Kopper O, Korving J, Begthel H, Vreuls CPH, van Es JH and Clevers H: Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. Nat Commun. 11:26602020. View Article : Google Scholar : PubMed/NCBI | |
Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, et al: Stage at diagnosis and ovarian cancer survival: Evidence from the international cancer benchmarking partnership. Gynecol Oncol. 127:75–82. 2012. View Article : Google Scholar : PubMed/NCBI | |
Ghose A, McCann L, Makker S, Mukherjee U, Gullapalli SVN, Erekkath J, Shih S, Mahajan I, Sanchez E, Uccello M, et al: Diagnostic biomarkers in ovarian cancer: Advances beyond CA125 and HE4. Ther Adv Med Oncol. 16:175883592412332252024. View Article : Google Scholar : PubMed/NCBI | |
Saani I, Raj N, Sood R, Ansari S, Mandviwala HA, Sanchez E and Boussios S: Clinical challenges in the management of malignant ovarian germ cell tumours. Int J Environ Res Public Health. 20:60892023. View Article : Google Scholar : PubMed/NCBI | |
Singh N: WHO classification of tumors of the ovary. In: Encyclopedia of Pathology. Van Krieken JHJM: Springer International Publishing; Cham: pp. 1–4. 2022 | |
Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J and Karlan BY: Ovarian cancer. Nat Rev Dis Primers. 2:160612016. View Article : Google Scholar : PubMed/NCBI | |
Pavlidis N, Rassy E, Vermorken JB, Assi T, Kattan J, Boussios S and Smith-Gagen J: The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry. Cancer Epidemiol. 75:1020452021. View Article : Google Scholar : PubMed/NCBI | |
Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, et al: Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol. 31:161–169. 2007. View Article : Google Scholar : PubMed/NCBI | |
Shih IM, Wang Y and Wang TL: The origin of ovarian cancer species and precancerous landscape. Am J Pathol. 191:26–39. 2021. View Article : Google Scholar : PubMed/NCBI | |
Aliyuda F, Moschetta M, Ghose A, Sofia Rallis K, Sheriff M, Sanchez E, Rassy E and Boussios S: Advances in ovarian cancer treatment beyond PARP Inhibitors. Curr Cancer Drug Targets. 23:433–446. 2023. View Article : Google Scholar : PubMed/NCBI | |
Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, et al: A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 211:26–35. 2007. View Article : Google Scholar : PubMed/NCBI | |
Colvin EK and Howell VM: Why the dual origins of high grade serous ovarian cancer matter. Nat Commun. 11:12002020. View Article : Google Scholar : PubMed/NCBI | |
Greten FR and Grivennikov SI: Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity. 51:27–41. 2019. View Article : Google Scholar : PubMed/NCBI | |
Łaniewski P, Ilhan ZE and Herbst-Kralovetz MM: The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 17:232–250. 2020. View Article : Google Scholar : PubMed/NCBI | |
Chambers LM, Bussies P, Vargas R, Esakov E, Tewari S, Reizes O and Michener C: The microbiome and gynecologic cancer: Current evidence and future opportunities. Curr Oncol Rep. 23:922021. View Article : Google Scholar : PubMed/NCBI | |
Jia D, Nagaoka Y, Katsumata M and Orsulic S: Inflammation is a key contributor to ovarian cancer cell seeding. Sci Rep. 8:123942018. View Article : Google Scholar : PubMed/NCBI | |
Sabatini ME and Chiocca S: Human papillomavirus as a driver of head and neck cancers. Br J Cancer. 122:306–314. 2020. View Article : Google Scholar : PubMed/NCBI | |
Demarco M, Hyun N, Carter-Pokras O, Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W, Gage JC, et al: A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs. EClinicalMedicine. 22:1002932020. View Article : Google Scholar : PubMed/NCBI | |
Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1129–1136. 1990. View Article : Google Scholar : PubMed/NCBI | |
Fischer M, Uxa S, Stanko C, Magin TM and Engeland K: Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway. Sci Rep. 7:26032017. View Article : Google Scholar : PubMed/NCBI | |
Cherif S, Amine A, Thies S, Taube ET, Braicu EI, Sehouli J and Kaufmann AM: Prevalence of human papillomavirus detection in ovarian cancer: A meta-analysis. Eur J Clin Microbiol Infect Dis. 40:1791–1802. 2021. View Article : Google Scholar : PubMed/NCBI | |
Ibragimova MK, Kokorina EV, Tsyganov MM, Churuksaeva ON and Litviakov NV: Human papillomavirus and ovarian cancer (review of literature and meta-analysis). Infect Genet Evol. 95:1050862021. View Article : Google Scholar : PubMed/NCBI | |
Grabarek BO, Ossowski P, Czarniecka J, Ożóg M, Prucnal J, Dziuba I, Ostenda A, Dziobek K, Boroń D, Peszek W, et al: Detection and genotyping of human papillomavirus (HPV16/18), Epstein-barr virus (EBV), and human cytomegalovirus (HCMV) in endometrial endometroid and ovarian cancers. Pathogens. 12:3972023. View Article : Google Scholar : PubMed/NCBI | |
Fatima B, Masud R, Sultana N, Javed A and Justin S: Detection of human papillomavirus in archival bladder and ovarian cancer samples. Clin Epidemiology Glob Health. 22:1013392023. View Article : Google Scholar | |
Kumar P, Ranmale S, Tongaonkar H, Mehta S and Mania-Pramanik J: Human papillomavirus infection: Is it associated with epithelial ovarian cancer? Indian J Med Microbiol. 39:311–314. 2021. View Article : Google Scholar : PubMed/NCBI | |
Yang X, You Q, Yao G, Geng J, Ma R and Meng H: Evaluation of p16 in epithelial ovarian cancer for a 10-year study in northeast China: Significance of HPV in correlation with PD-L1 expression. Cancer Manag Res. 12:6747–6753. 2020. View Article : Google Scholar : PubMed/NCBI | |
Shokouh MR, Safaei A, Moattari A and Sarvari J: Association of human papilloma virus and Epstein-barr virus with ovarian cancer in Shiraz, southwestern Iran. Iran J Pathol. 15:292–298. 2020. View Article : Google Scholar : PubMed/NCBI | |
Kisseljova N, Zhordania K, Fedorova M, Katargin A, Valeeva A, Pajanidi J, Pavlova L, Khvan O and Vinokurova S: Detection of human papillomavirus prevalence in ovarian cancer by different test systems. Intervirology. 62:198–204. 2019. View Article : Google Scholar : PubMed/NCBI | |
Paradowska E, Jabłońska A, Studzińska M, Wilczyński M and Wilczyński JR: Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients. Sci Rep. 9:199352019. View Article : Google Scholar : PubMed/NCBI | |
Hammou RA, Benhessou M, Bouziyane A, Hassou N, Benhchekroun MN, Bessi H and Ennaji MM: Oncogenic human papillomavirus involvement in epithelial ovarian carcinoma among women in Morocco. Bioinformation. 15:55–60. 2019. View Article : Google Scholar : PubMed/NCBI | |
Hassan ZK, Hafez MM, Kamel MM and Zekri ARN: Human Papillomavirus genotypes and methylation of CADM1, PAX1, MAL and ADCYAP1 genes in epithelial ovarian cancer patients. Asian Pac J Cancer Prev. 18:169–176. 2017.PubMed/NCBI | |
Farzaneh F, Nadji SA, Khosravi D, Hosseini MS, Hashemi Bahremani M, Chehrazi M, Bagheri G, Sigaroodi A and Haghighatian Z: Lack of HPV in benign and malignant epithelial ovarian tumors in Iran. Asian Pac J Cancer Prev. 18:1233–1236. 2017.PubMed/NCBI | |
Dadashi M, Eslami G, Faghihloo E, Pourmohammad A, Hosseini J, Taheripanah R and Arab-Mazar Z: Detection of human papilloma virus type 16 in epithelial ovarian tumors samples. Arch Clin Infect Dis. 12:e396662017. | |
Zhang PP, Zhou L, Cao JS, Li YP, Zeng Z, Sun N, Shen L, Zhu HY, Ruan Y, Zha WT, et al: Possible epithelial ovarian cancer association with HPV18 or HPV33 infection. Asian Pac J Cancer Prev. 17:2959–2964. 2016.PubMed/NCBI | |
Ingerslev K, Hogdall E, Skovrider-Ruminski W, Schnack TH, Karlsen MA, Nedergaard L, Hogdall C and Blaakær J: High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population. Infect Agent Cancer. 11:392016. View Article : Google Scholar : PubMed/NCBI | |
Mahmood FM, Kadhim HS and Mousa Al Khuzaee LR: Detection of human papillomavirus-16 E6-oncoprotein in epithelial ovarian tumors samples of Iraqi patients. Jundishapur J Microbiol. 7:e119452014.PubMed/NCBI | |
Al-Shabanah OA, Hafez MM, Hassan ZK, Sayed-Ahmed MM, Abozeed WN, Alsheikh A and Al-Rejaie SS: Methylation of SFRPs and APC genes in ovarian cancer infected with high risk human papillomavirus. Asian Pac J Cancer Prev. 15:2719–2725. 2014. View Article : Google Scholar : PubMed/NCBI | |
Al-Shabanah OA, Hafez MM, Hassan ZK, Sayed-Ahmed MM, Abozeed WN, Al-Rejaie SS and Alsheikh AA: Human papillomavirus genotyping and integration in ovarian cancer Saudi patients. Virol J. 10:3432013. View Article : Google Scholar : PubMed/NCBI | |
Malisic E, Jankovic R and Jakovljevic K: Detection and genotyping of human papillomaviruses and their role in the development of ovarian carcinomas. Arch Gynecol Obstet. 286:723–728. 2012. View Article : Google Scholar : PubMed/NCBI | |
Shanmughapriya S, SenthilKumar G, Vinodhini K, Das BC, Vasanthi N and Natarajaseenivasan K: Viral and bacterial aetiologies of epithelial ovarian cancer. Eur J Clin Microbiol Infect Dis. 31:2311–2317. 2012. View Article : Google Scholar : PubMed/NCBI | |
Alavi G, Sharifi N, Sadeghian A, Rezaei A and Shidaee H: Failure to demonstrate the role of high risk human papilloma virus in epithelial ovarian cancer. Iran J Pathol. 7:151–156. 2012. | |
Bilyk OO, Pande NT and Buchynska LG: Analysis of P53, P16INK4A, PRB and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas. Exp Oncol. 33:150–156. 2011.PubMed/NCBI | |
Idahl A, Lundin E, Elgh F, Jurstrand M, Møller JK, Marklund I, Lindgren P and Ottander U: Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions. Am J Obstet Gynecol. 202:71.e1–e6. 2010. View Article : Google Scholar : PubMed/NCBI | |
Wentzensen N, du Bois A, Kommoss S, Pfisterer J, Von Knebel Doeberitz M, Schmidt D and Kommoss F: No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: An analysis of the AGO ovarian cancer study group. Int J Gynecol Pathol. 27:18–23. 2008. View Article : Google Scholar : PubMed/NCBI | |
Giordano G, D'Adda T, Gnetti L, Froio E, Merisio C and Melpignano M: Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women. J Obstet Gynaecol. 34:210–217. 2008. View Article : Google Scholar : PubMed/NCBI | |
Atalay F, Taskiran C, Taner MZ, Pak I, Or M and Tuncer S: Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma. J Obstet Gynaecol. 33:823–828. 2007. View Article : Google Scholar : PubMed/NCBI | |
Konidaris S, Kouskouni EE, Panoskaltsis T, Kreatsas G, Patsouris ES, Sarivalassis A, Nonni A and Lazaris AC: Human papillomavirus infection in malignant and benign gynaecological conditions: A study in Greek women. Health Care Women Int. 28:182–191. 2007. View Article : Google Scholar : PubMed/NCBI | |
Quirk JT, Kupinski JM and DiCioccio RA: Analysis of ovarian tumors for the presence of human papillomavirus DNA. J Obstet Gynaecol. 32:202–205. 2006. View Article : Google Scholar : PubMed/NCBI | |
Kuscu E, Ozdemir BH, Erkanli S and Haberal A: HPV and p53 expression in epithelial ovarian carcinoma. Eur J Gynaecol Oncol. 26:642–645. 2005.PubMed/NCBI | |
Elishaev E, Gilks CB, Miller D, Srodon M, Kurman RJ and Ronnett BM: Synchronous and metachronous endocervical and ovarian neoplasms: Evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms. Am J Surg Pathol. 29:281–294. 2005. View Article : Google Scholar : PubMed/NCBI | |
Yang HJ, Liu VW, Tsang PC, Yip AM, Ng TY, Cheung AN and Ngan HY: Comparison of human papillomavirus DNA levels in gynecological cancers: Implication for cancer development. Tumor Biol. 24:310–316. 2003. View Article : Google Scholar | |
Wu QJ, Guo M, Lu ZM, Li T, Qiao HZ and Ke Y: Detection of human papillomavirus-16 in ovarian malignancy. Br J Cancer. 89:672–675. 2003. View Article : Google Scholar : PubMed/NCBI | |
Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing HP, Mei Q and Ke Y: p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer. 95:2571–2576. 2002. View Article : Google Scholar : PubMed/NCBI | |
Ip SM, Wong LC, Xu CM, Cheung AN, Tsang PC and Ngan HY: Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of the upper genital tract. Gynecol Oncol. 87:104–111. 2002. View Article : Google Scholar : PubMed/NCBI | |
Chen TR, Chan PJ, Seraj IM and King A: Absence of human papillomavirus E6-E7 transforming genes from HPV 16 and 18 in malignant ovarian carcinoma. Gynecol Oncol. 72:180–182. 1999. View Article : Google Scholar : PubMed/NCBI | |
Anttila M, Syrjänen S, Ji H, Saarikoski S and Syrjänen K: Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol. 72:337–341. 1999. View Article : Google Scholar : PubMed/NCBI | |
Zimna K, Poreba E, Kedzia W, Gozdzicka-Józefiak A and Kezia H: Human papillomavirus (HPV) in upper genital tract carcinomas of women. Eur J Gynaecol Oncol. 18:415–417. 1997.PubMed/NCBI | |
Anwar K, Nakakuki K, Imai H, Shiraishi T and Inuzuka M: Infection of human papillomavirus (HPV) and p53 over-expression in human female genital tract carcinoma. J Pak Med Assoc. 46:220–224. 1996.PubMed/NCBI | |
Trottier AM, Provencher D, Mes-Masson AM, Vauclair R and Coutlée F: Absence of human papillomavirus sequences in ovarian pathologies. J Clin Microbiol. 33:1011–1013. 1995. View Article : Google Scholar : PubMed/NCBI | |
Runnebaum IB, Maier S, Tong XW, Rosenthal HE, Möbus VJ, Kieback DG and Kreienberg R: Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients. Cancer Epidemiol Biomarkers Prev. 4:573–575. 1995.PubMed/NCBI | |
Lai CH, Wang CY, Lin CY and Pao CC: Detection of human papillomavirus RNA in ovarian and endometrial carcinomas by reverse transcription/polymerase chain reaction. Gynecol Obstet Invest. 38:276–280. 1994. View Article : Google Scholar : PubMed/NCBI | |
Lai CH, Hsueh S, Lin CY, Huang MY, You GB, Chang HC and Pao CC: Human papillomavirus in benign and malignant ovarian and endometrial tissues. Int J Gynecol Pathol. 11:210–215. 1992. View Article : Google Scholar : PubMed/NCBI | |
Beckmann AM, Sherman KJ, Saran L and Weiss NS: Genital-type human papillomavirus infection is not associated with surface epithelial ovarian carcinoma. Gynecol Oncol. 43:247–251. 1991. View Article : Google Scholar : PubMed/NCBI | |
McLellan R, Buscema J, Guerrero E, Shah KV, Woodruff JD and Currie JL: Investigation of ovarian neoplasia of low malignant potential for human papillomavirus. Gynecol Oncol. 38:383–385. 1990. View Article : Google Scholar : PubMed/NCBI | |
Leake JF, Woodruff JD, Searle C, Daniel R, Shah KV and Currie JL: Human papillomavirus and epithelial ovarian neoplasia. Gynecol Oncol. 34:263–273. 1989. View Article : Google Scholar | |
Nikolakopoulou A, Mavridis D and Salanti G: Demystifying fixed and random effects meta-analysis. BMJ Ment Health. 17:53–57. 2014. | |
Schwarzer G: meta: An R package for meta-analysis. R News. 7:40–45. 2007. | |
Higgins JP and Green S: Cochrane handbook for systematic reviews of interventions. In: Cochrane Handbook for Systematic Reviews of Interventions. Wiley; 2019 | |
Paule RC and Mandel J: Consensus values and weighting factors. J Res Natl Bur Stand (1977). 87:377–385. 1982. View Article : Google Scholar : PubMed/NCBI | |
Balduzzi S, Rücker G and Schwarzer G: How to perform a meta-analysis with R: A practical tutorial. Evid Based Ment Health. 22:153–160. 2019. View Article : Google Scholar : PubMed/NCBI | |
Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rücker G, Harbord RM, Schmid CH, et al: Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 343:d40022011. View Article : Google Scholar : PubMed/NCBI | |
Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics. 50:1088–1101. 1994. View Article : Google Scholar : PubMed/NCBI | |
Peters JL, Sutton AJ, Jones DR, Abrams KR and Rushton L: Comparison of two methods to detect publication bias in meta-analysis. JAMA. 295:676–680. 2006. View Article : Google Scholar : PubMed/NCBI | |
Viechtbauer W: Conducting meta-analyses in R with the metafor package. J Stat Soft. 36:1–48. 2010. View Article : Google Scholar | |
R Core Team, . R: A language and environment for statistical computing. R Foundation for Statistical Computing; Vienna: 2023 | |
Schwarzer G, Carpenter JR and Rücker G: metasens: Statistical methods for sensitivity analysis in meta-analysis. R package version 1.5–2. https://CRAN.R-project.org/package=metasens | |
Halec G, Alemany L, Quiros B, Clavero O, Höfler D, Alejo M, Quint W, Pawlita M, Bosch FX and de Sanjose S: Biological relevance of human papillomaviruses in vulvar cancer. Mod Pathol. 30:549–562. 2017. View Article : Google Scholar : PubMed/NCBI | |
Lechner M, Liu J, Masterson L and Fenton TR: HPV-associated oropharyngeal cancer: Epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 19:306–327. 2022. View Article : Google Scholar : PubMed/NCBI | |
Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SO and Dillner J: Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer. 87:61–64. 2002. View Article : Google Scholar : PubMed/NCBI | |
Cohen PA, Jhingran A, Oaknin A and Denny L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI | |
Chan PJ, Seraj IM, Kalugdan TH and King A: Evidence for ease of transmission of human papillomavirus DNA from sperm to cells of the uterus and embryo. J Assist Reprod Genet. 13:516–519. 1996. View Article : Google Scholar : PubMed/NCBI | |
Dyson N, Howley PM, Münger K and Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 243:934–937. 1989. View Article : Google Scholar : PubMed/NCBI | |
Hashiguchi Y, Tsuda H, Yamamoto K, Inoue T, Ishiko O and Ogita S: Combined analysis of p53 and RB pathways in epithelial ovarian cancer. Hum Pathol. 32:988–996. 2001. View Article : Google Scholar : PubMed/NCBI | |
Bruni L, Albero G, Serrano B, Mena M, Collado J, Gómez D, Muñoz J, Bosch F and de Sanjosé S: ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human papillomavirus and related diseases in the world. Summary Report 10 March 2023. https://hpvcentre.net/statistics/reports/XWX.pdfOctober 8–2023 |